These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25826032)

  • 1. [Myocardial revascularization: the new European guidelines].
    Fröhlich G; Landmesser U
    Dtsch Med Wochenschr; 2015 Apr; 140(7):492-4. PubMed ID: 25826032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The year in cardiology 2015: coronary intervention.
    Steg PG; Serruys PW; Abdelghani M; Wijns W
    Eur Heart J; 2016 Jan; 37(4):335-43. PubMed ID: 26726048
    [No Abstract]   [Full Text] [Related]  

  • 5. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Kolh P; Windecker S; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; ; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol Ç; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; ; Sousa Uva M; Achenbach S; Pepper J; Anyanwu A; Badimon L; Bauersachs J; Baumbach A; Beygui F; Bonaros N; De Carlo M; Deaton C; Dobrev D; Dunning J; Eeckhout E; Gielen S; Hasdai D; Kirchhof P; Luckraz H; Mahrholdt H; Montalescot G; Paparella D; Rastan AJ; Sanmartin M; Sergeant P; Silber S; Tamargo J; ten Berg J; Thiele H; van Geuns RJ; Wagner HO; Wassmann S; Wendler O; Zamorano JL; ;
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):517-92. PubMed ID: 25173601
    [No Abstract]   [Full Text] [Related]  

  • 6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint ESC/EACTS guidelines on myocardial revascularization.
    Kolh P; Wijns W
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):264-7. PubMed ID: 21372739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
    Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
    Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cardiac surgery and antiplatelet therapy following coronary artery stenting.
    Luckie M; Khattar RS; Fraser D
    Heart; 2009 Aug; 95(16):1303-8. PubMed ID: 19218260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe.
    Ferrières J; Sartral M; Tcherny-Lessenot S; Belger M;
    Arch Cardiovasc Dis; 2011 Feb; 104(2):104-14. PubMed ID: 21402345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.
    Serebruany VL; DiNicolantonio JJ
    Thromb Haemost; 2013 Jul; 110(1):5-10. PubMed ID: 23743577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents.
    van Kuijk JP; Flu WJ; Schouten O; Hoeks SE; Schenkeveld L; de Jaegere PP; Bax JJ; van Domburg RT; Serruys PW; Poldermans D
    Am J Cardiol; 2009 Nov; 104(9):1229-34. PubMed ID: 19840567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group.
    Staritz P; de Moerloose P; Schutgens R; Dolan G;
    Haemophilia; 2013 Nov; 19(6):833-40. PubMed ID: 23710576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments in dual antiplatelet therapy after stenting.
    Giacoppo D; Baber U; Mehran R
    Minerva Cardioangiol; 2014 Jun; 62(3):261-76. PubMed ID: 24831762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of non-ST-segment elevation acute coronary syndrome: comparison of the updated guidelines from North America and Europe.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2012 Jun; 11(2):62-73. PubMed ID: 22595816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-eluting stents: do we respect the on-label use in our daily practice?].
    Puymirat E; Chaib A; Chaudeurge A; Trinquart L; Ledru F; Durand E; Danchin N; Blanchard D
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):196-204. PubMed ID: 20708171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.